Cargando…

Protection of abasic sites during DNA replication by a stable thiazolidine protein-DNA crosslink

Abasic (AP) sites are one of the most common DNA lesions that block replicative polymerases. HMCES recognizes and processes these lesions in the context of single-stranded DNA (ssDNA). A HMCES DNA-protein crosslink (DPC) intermediate is thought to shield the AP site from endonucleases and error-pron...

Descripción completa

Detalles Bibliográficos
Autores principales: Thompson, Petria S., Amidon, Katherine M., Mohni, Kareem N., Cortez, David, Eichman, Brandt F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628887/
https://www.ncbi.nlm.nih.gov/pubmed/31235915
http://dx.doi.org/10.1038/s41594-019-0255-5
Descripción
Sumario:Abasic (AP) sites are one of the most common DNA lesions that block replicative polymerases. HMCES recognizes and processes these lesions in the context of single-stranded DNA (ssDNA). A HMCES DNA-protein crosslink (DPC) intermediate is thought to shield the AP site from endonucleases and error-prone polymerases. The highly evolutionarily conserved SRAP domain of HMCES and its Escherichia coli ortholog YedK mediate lesion recognition. Here we discover the basis of AP site protection by SRAP domains from a crystal structure of the YedK DPC. YedK forms a stable thiazolidine linkage between a ring-opened AP site and the α-amino and sulfhydryl substituents of its N-terminal cysteine residue. The thiazolidine linkage explains the remarkable stability of the HMCES DPC, its resistance to strand cleavage, and the proteolysis requirement for resolution. Furthermore, its structure reveals that HMCES has specificity for AP sites in ssDNA at junctions found when replicative polymerases encounter the AP lesion.